DIFLUNISAL

Diflunisal is an NSAID inhibiting COX enzymes to reduce pain and inflammation. Side effects include GI upset, bleeding risk, and kidney impairment. Only GMP materials will be supplied, logistics all according to GDP.

SKU: e636fd13ca18 Category: Tag:

Product Description


Mechanism of Action

Diflunisal is a salicylicacid derivative NSAID that noncompetitively inhibits cyclooxygenase enzymes (COX1 and COX2). This decreases prostaglandin synthesis, reducing inflammation, pain and fever. Its difluorophenyl ring confers longer halflife and reduced CNS penetration compared to aspirin.

Benefits and Advantages

Used in COXpathway modelling, analgesic SAR research, prostaglandin signalling analysis, and inflammatorycascade studies.

Side Effects and Risks

Risks include GI irritation, renal stress, bleeding tendency, hypersensitivity, hepatotoxicity and fluid retention. Handle with NSAIDclass safety procedures.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C13H8F2O3

Molecular Weight

250.20 g/mol

CAS Number

22494-42-4

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Practically insoluble (14.5 mg/L) at neutral or acidic pH.

Purity

Purity information is available upon request (COA).

Synonym

diflunisal; 22494-42-4; Dolobid; Dolobis; Flovacil

IUPAC/Chemical Name

5-(2,4-difluorophenyl)-2-hydroxybenzoic acid

InChl Key

HUPFGZXOMWLGNK-UHFFFAOYSA-N

InChl Code

InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)

References

https://pubchem.ncbi.nlm.nih.gov/compound/3059;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download